Alzamend Neuro Inc reports results for the quarter ended in July - Earnings Summary

Alzamend Neuro

13/09/2023 23:21

* Alzamend Neuro Inc  ALZN.OQ  reported a quarterly adjusted
loss
of 4 cents​​ per share for the quarter ended in July. The mean
expectation of two analysts for the quarter was for a loss of 4
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Alzamend Neuro Inc's reported EPS for the quarter was a
loss
of 4 cents​.
    * The mean earnings estimate of analysts had risen by
about 22.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Alzamend Neuro Inc shares had fallen by 54.7% this
quarter and
lost 59.1% so far this year.
    * The company reported a quarterly loss of $3.53 million.
    * Wall Street's median 12-month price target for Alzamend
Neuro
Inc is $3.88 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
September 13 at 10:21 p.m. UTC. ​All figures in US dollars
unless otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jul. 31 2023      -0.03          -0.04          Missed
 Apr. 30 2023      -0.04          -0.03          Beat
 Jan. 31 2023      -0.04          -0.06          Missed
 Oct. 31 2022      -0.04          -0.03          Beat